Last Updated: August 15, 2026

Litigation Details for ALLERGAN, INC. v. APOTEX INC (M.D.N.C. 2013)


✉ Email this page to a colleague

« Back to Dashboard


ALLERGAN, INC. v. APOTEX INC (M.D.N.C. 2013)

Docket 1:13-cv-00016 Date Filed 2013-01-08
Court District Court, M.D. North Carolina Date Terminated 2015-01-20
Cause 35:271 Patent Infringement Assigned To Catherine Caldwell Eagles
Jury Demand Both Referred To Lawrence Patrick Auld
Patents 7,351,404; 8,038,988; 8,101,161; 8,263,054
Link to Docket External link to docket
Small Molecule Drugs cited in ALLERGAN, INC. v. APOTEX INC
The small molecule drug covered by the patents cited in this case is ⤷  Start Trial .

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.